Dihydroartemisinin inhibits the viability of cervical cancer cells by upregulating caveolin 1 and mitochondrial carrier homolog 2: Involvement of p53 activation and NAD(P)H:quinone oxidoreductase 1 downregulation

Ting Zhang(National Institutes of Health), Peiling Cai(Chengdu University)

International Journal of Molecular Medicine

May 9, 2017

10.3892/ijmm.2017.2980

Cited by 23

Related Papers

Sclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells

|Molecular Medicine Reports|2017|40

Protection of photoreceptors by intravitreal injection of the Y-27632 Rho-associated protein kinase inhibitor in Royal College of Surgeons rats

|Molecular Medicine Reports|2015|24

Proteomic characterization of endogenous substrates of mammalian ubiquitin ligase Hrd1

|Cell & Bioscience|2018|24

Uncoupling Protein 2 Deficiency Enhances NLRP3 Inflammasome Activation Following Hyperglycemia-Induced Exacerbation of Cerebral Ischemia and Reperfusion Damage In Vitro and In Vivo

|Neurochemical Research|2021|14

1,25‑dihydroxyvitamin D3 enhances the susceptibility of anaplastic thyroid cancer cells to adriamycin‑induced apoptosis by increasing the generation of reactive oxygen species

|Molecular Medicine Reports|2019|8